October 23, 2014
Authored and Edited by Naresh Kilaru
The Court of Appeals for the Third Circuit recently considered whether plaintiffs bringing a Lanham Act false advertising claim and seeking a preliminary injunction are entitled to a presumption of irreparable harm upon showing a likelihood of success on the merits. It joined the growing chorus of courts holding that no such presumption exists in view of the Supreme Court’s eBay decision. Ferring Pharm., Inc. v. Watson Pharm., Inc., 765 F.3d 205 (3d Cir. 2014).
Plaintiff accused defendant of making certain false and misleading statements in two webcast presentations to doctors (the parties were competing manufacturers of pharmaceutical products). The defendant conceded that certain of the statements were made in error and certified to the court that it would not repeat such statements in the future. The defendant also agreed to clarify other statements moving forward. The district court denied plaintiff’s motion for a preliminary injunction after finding that plaintiff failed to present sufficient evidence to demonstrate a likelihood of irreparable harm.
The plaintiff appealed the denial of its motion for a preliminary injunction, and the Third Circuit affirmed. It noted that, prior to eBay, several circuit courts had applied a presumption of irreparable harm in Lanham Act false advertising cases. Circuit courts after eBay, however, have “uniformly” held that a presumption of irreparable harm is no longer permissible. As the Supreme Court noted in eBay, applying such a presumption deviates from traditional principles of equity requiring that a movant actually demonstrate the likelihood of irreparable harm.
In this case, the only evidence of irreparable harm submitted by the plaintiff was a declaration from a physician stating that she and other doctors would be less likely to prescribe the plaintiff’s drug after hearing the defendant’s allegedly false statements. Like the district court, the Third Circuit found the declaration to be speculative because it did not state that the physician had, in fact, prescribed the plaintiff’s product less frequently. The court also found no irreparable harm because the defendant had immediately removed certain of the statements from the webcast and agreed to clarify other statements moving forward.
This case is yet another post-eBay example of how the irreparable-harm factor is becoming the overriding factor in the preliminary injunction analysis. Indeed, the district court in this case noted that it did not need to even consider the plaintiff’s likelihood of success on the merits given the failure to demonstrate a likelihood of irreparable harm.
Copyright © 2014 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
At the PTAB Blog
USPTO Releases Notice of Proposed Rule Making Codifying Several Precedential Case Factors
April 25, 2024
Ad Law Buzz Blog
“Banning” a Banned Ingredients Claim: NAD’s Application (and Expansion) of the FTC’s Green Guides
March 18, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.